Celgene Corp. (CELG) reported first-quarter of net income of $385 million or $0.89 per share, compared to $402 million or $0.90 per share last year. Adjusted net income increased 22 percent to $592 million from $484 million prior year. Adjusted profit per share increased to $1.37 from $1.08. Net product sales were $1.43 billion, a 15 percent increase from the same period in 2012. Total revenue was $1.47 billion, compared to $1.27 billion prior year.
Adjusted R&D expenses were $330 million compared to $315 million last year. The increase is primarily due to milestone payments for existing research collaborations, the company said. On a GAAP basis, R&D expenses were $452 million compared to $362 million last year. GAAP R&D expenses increased primarily due to upfront payments for new collaborations entered into during the quarter.
On average, 29 analysts polled by Thomson Reuters expected the company to report profit of $1.35 per share for the quarter. Analysts' estimates typically exclude special items. Analysts expected revenue of $1.47 billion for the quarter.
The company expects its fiscal 2013 total net product sales to increase approximately 11 percent year-over-year to $6 billion. The company raised its fiscal 2013 adjusted profit per share guidance to a range of $5.55 to $5.65 from a range of $5.50 to $5.60. GAAP profit per share is expected to be in the range of $4.32 to $4.47. Analysts expect the company to report fiscal 2013 profit per share of $5.70 on revenue of $6.13 billion.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.